Want to track NOVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novartis AG (NOVN) Statistics
Valuation metrics
Market Cap -
Enterprise value 246.74B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 6.3
Enterprise Value/Revenue 5.07
Enterprise Value/EBITDA 12.51
Overview
Shares outstanding -
Float 1.82B
Shares short -
% Held by insiders 0.02%
% Held by institutions 0.43%
Average volume (10 days) 1
Average volume (90 days) 2
Price summary
52-Week low 97.09
52-Week high 143.52
Beta 0.49
50-Day moving average 129.65
200-Day moving average 118.91
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 4.67
Trailing annual dividend yield 0.0364%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 17 Mar 2026
Ex-Dividend Date 10 Mar 2026
Last split factor 6:5
Last split Date 4 Oct 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.24%
Operating margin 0.3%
Operational effectiveness
Return on assets 0.11%
Return on equity 0.35%
Income Statement
Revenue (ttm) 48.69B
Revenue per share (ttm) 29.4
Quarterly revenue growth (yoy) -0.01%
Gross profit (ttm) 36.78B
EBITDA 19.72B
Net income to common (ttm) 11.65B
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -0.12%
Balance Sheet
Total cash (mrq) 5.93B
Total cash per share (mrq) 3.61
Total debt (mrq) 40.44B
Total Debt/Equity (mrq) 120.73
Current ratio (mrq) 0.85%
Book value per share (mrq) 20.49
Cash Flow
Cash flow statement 16.5B
Levered free cash flow (LFCF) 10.35B
